Chris Bock

Title: Chris Bock: Innovator in Aptamer Technology

Introduction

Chris Bock is an accomplished inventor based in Cleveland Heights, OH (US). He has made significant contributions to the field of aptamer technology, particularly through his innovative methods for generating aptamers with improved off-rates. His work has the potential to advance various applications in molecular biology and therapeutic development.

Latest Patents

Chris Bock holds a patent for a "Method for generating aptamers with improved off-rates." This patent describes enhanced SELEX methods for producing aptamers that can effectively bind to target molecules. Additionally, it outlines improved photoSELEX methods for creating photoreactive aptamers capable of both binding and covalently crosslinking to target molecules. The methods presented in this patent result in aptamers and photoaptamers that exhibit slower dissociation rate constants compared to those produced by prior techniques. Furthermore, the patent details aptamer constructs that incorporate various functionalities, including cleavable elements, detection elements, and capture or immobilization elements.

Career Highlights

Chris Bock is currently associated with Somalogic Operating Co., Inc., where he continues to push the boundaries of aptamer research. His work at Somalogic has positioned him as a key player in the development of innovative solutions in the biotechnology sector.

Collaborations

Chris collaborates with talented individuals such as Dominic Zichi and Sheri K Wilcox, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Chris Bock's contributions to aptamer technology exemplify the impact of innovative thinking in the field of molecular biology. His patent and ongoing work at Somalogic highlight the importance of advancements in this area, paving the way for future developments.